Suzanne F Jones (Suzanne Jones)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Prognostic Factors

End Stage Renal Disease

Ejection Fraction

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

Targeted oncology

Investigational new drugs

This page only lists publications with an associated author ORCID identifier.

Publications

Todd M Bauer, Kathleen M Moore, Janet S Rader, Fiona Simpkins, Alain C Mita, J Thaddeus Beck, Lowell Hart, Quincy Chu, Amit Oza, Sarah A Cook, Esteban Rodrigo Imedio, Sanjeev Kumar, Ganesh M Mugundu, Suzanne Jenkins, Juliann Chmielecki, Suzanne F Jones, David R Spigel, Siqing Fu
A Phase Ib Study Assessing the Safety, Tolerability, and Efficacy of the First-in-Class Wee1 Inhibitor Adavosertib (AZD1775) as Monotherapy in Patients with Advanced Solid Tumors. Targeted oncology (2023)
Gerald S Falchook, Jasgit C Sachdev, Esteban Rodrigo Imedio, Sanjeev Kumar, Ganesh M Mugundu, Suzanne Jenkins, Juliann Chmielecki, Suzanne F Jones, David R Spigel, Melissa Lynne Johnson
A phase Ib study of adavosertib, a selective Wee1 inhibitor, in patients with locally advanced or metastatic solid tumors. Investigational new drugs (2023)
Emma G Sturgill, Amanda Misch, Rebecca Lachs, Carissa C Jones, Dan Schlauch, Suzanne F Jones, Mythili Shastry, Denise A Yardley, Howard A Burris, David R Spigel, Erika Paige Hamilton, Andrew J McKenzie
Next-Generation Sequencing of Patients With Breast Cancer in Community Oncology Clinics. JCO precision oncology 5 (2022)
Daniel Schlauch, Xiaotong Fu, Suzanne F Jones, Howard A Burris, David R Spigel, James Reeves, Andrew J McKenzie
Tumor-Specific and Tumor-Agnostic Molecular Signatures Associated With Response to Immune Checkpoint Inhibitors. JCO precision oncology 5 (2022)
Alexander I Spira, Mark D Stewart, Suzanne F Jones, Elaine Chang, Anitra Fielding, Nicole Richie, Laura S Wood, Michael A Thompson, Abhilasha Nair, Brandon A Mahal, David E Gerber
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Laboratory Reference Ranges and Testing Intervals Work Group. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (9) (2021)
David S Hong, Kathleen M Moore, Johanna C Bendell, Daniel D Karp, Judy S Wang, Susanna V Ulahannan, Suzanne F Jones, Wenjuan Wu, Gregory P Donoho, Yan Ding, Andrew Capen, Aimee Bence Lin, Manish R Patel
Preclinical Evaluation and Phase Ib Study of Prexasertib, a CHK1 Inhibitor, and Samotolisib (LY3023414), a Dual PI3K/mTOR Inhibitor. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (7) (2021)
Kathleen M Moore, Setsuko K Chambers, Erika P Hamilton, Lee-May Chen, Amit M Oza, Sharad A Ghamande, Gottfried E Konecny, Steven C Plaxe, Daniel L Spitz, Jill J J Geenen, Tiffany A Troso-Sandoval, Janiel M Cragun, Esteban Rodrigo Imedio, Sanjeev Kumar, Ganesh M Mugundu, Zhongwu Lai, Juliann Chmielecki, Suzanne F Jones, David R Spigel, Karen A Cadoo
Adavosertib with Chemotherapy in Patients with Primary Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer: An Open-Label, Four-Arm, Phase II Study. Clinical cancer research : an official journal of the American Association for Cancer Research (2021)